Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 5:48 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 3,095 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cerebrovascular Disease Clear all

Conditions: Fabry Disease
Interventions: Migalastat HCl, Agalsidase Beta, Agalsidase Alfa; Drug · Biological
Lead sponsor: Amicus Therapeutics; Industry
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 5
States / cities: Birmingham, Alabama • Decatur, Georgia • Iowa City, Iowa + 2 more

Conditions: Resilience, Stroke
Interventions: Res-ET intervention; Other
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 55 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Intracerebral Hemorrhage, Intracerebral Haemorrhage, Intraventricular Hemorrhage, Stroke, Cerebrovascular Disease
Interventions: Reversal of Oral anticoagulation within 30 minutes, Early intensive blood pressure lowering, Treatment of pyrexia, Hyperglycemia treatment, Do-not-resuscitate (DNR) or withdrawal of care, Referral to Intensive Care, Referral to Neurosurgery, Repeat brain imaging, Standard care; Other · Diagnostic Test
Lead sponsor: Region Skane; Other
Eligibility: 18 Years and older
Enrollment: 3,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Ruptured Cerebral Aneurysm, Subarachnoid Hemorrhage (SAH)
Interventions: coil embolization, clip occlusion; Procedure
Lead sponsor: St. Joseph's Hospital and Medical Center, Phoenix; Other
Eligibility: 18 Years to 80 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2023
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Traumatic Brain Injury, Vascular Accident, Brain
Interventions: Brain Fitness Program, Weekly Telephone Contact; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 70 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Surgeries Undergoing General Anesthesia
Interventions: Lower FiO2, Intermediate FiO2, Higher FiO2; Other
Lead sponsor: Frederic T Billings IV; Other
Eligibility: 18 Years and older
Enrollment: 54,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 4
States / cities: Ann Arbor, Michigan • Omaha, Nebraska • Nashville, Tennessee + 1 more

Conditions: Stroke
Interventions: Miraπ, Mirror Therapy; Device · Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Bridgeport, Connecticut

Conditions: Octa, Stroke, Subarachnoid Hemorrhage, Intracerebral Hemorrhage
Interventions: OCTA; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Stroke, Hypertension
Interventions: Primary Care Physician Management of blood pressure, Withings Smart Blood Pressure Monitor; Other · Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 100 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Intracranial Aneurysms, Aneurysm, Brain Aneurysm
Interventions: Balloon Assisted Coiling using MicroVention second-generation hydrogel coils and MicroVention Scepter Occlusion Balloon Catheter.; Device
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Stroke, Hemiplegia
Interventions: Theraband with exercise video, usual care with advice to exercise; Device · Other
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: San Diego, California

Conditions: Stroke, Stroke Sequelae, Depression, Cognitive Impairment
Interventions: Mindfulness Based Stress Reduction (MBSR), Stroke Support Group (SSG); Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Aphasia, Stroke
Interventions: Anodal transcranial direct current stimulation, Sham transcranial direct current stimulation, Speech-language therapy; Device · Behavioral
Lead sponsor: Louisiana State University and A&M College; Other
Eligibility: 18 Years to 85 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Giant Cell Arteritis, Temporal Arteritis, Horton's Disease
Interventions: Ustekinumab, Prednisone; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 50 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Carotid Stenosis, Constriction, Pathologic, Carotid Artery Diseases, Cerebrovascular Disorders, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Arterial Occlusive Diseases, Vascular Diseases, Cardiovascular Diseases, Pathological Conditions, Anatomical
Interventions: Gore Flow Reversal System, Gore Embolic Filter; Device
Lead sponsor: W.L.Gore & Associates; Industry
Eligibility: 18 Years and older
Enrollment: 1,397 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 39
States / cities: Flagstaff, Arizona • Newport Beach, California • San Francisco, California + 34 more

Conditions: Subarachnoid Hemorrhage
Interventions: Spinal catheter insertion with extracorporeal filtration of CSF; Device
Lead sponsor: Minnetronix; Industry
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 4
States / cities: Minneapolis, Minnesota • Durham, North Carolina • Philadelphia, Pennsylvania + 1 more

Conditions: Intracranial Hemorrhage Ruptured Aneurysm
Interventions: surgical management, Endovascular management; Procedure
Lead sponsor: Centre hospitalier de l'Université de Montréal (CHUM); Other
Eligibility: 18 Years and older
Enrollment: 1,724 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2024
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Alzheimer Disease, Dementia, Dementia, Vascular, Pain
Interventions: hydrocodone/APAP w placebo PRN, hydrocodone/APAP, placebo with hydrocodone/APAP PRN; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 55 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2014
U.S. locations: 3
States / cities: Tuscaloosa, Alabama

Conditions: Dementia, Alzheimer Disease, Lewy Body Disease, Vascular Dementia, Frontotemporal Dementia, Mixed Dementia
Interventions: Kinto Care Coaching; Behavioral
Lead sponsor: Kinto; Industry
Eligibility: 18 Years and older
Enrollment: 495 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cardiac Arrest, Out-Of-Hospital, Hypothermia, Induced, Hypoxia-Ischemia, Brain
Interventions: Therapeutic Hypothermia; Device
Lead sponsor: University of Michigan; Other
Eligibility: 2 Days to 17 Years
Enrollment: 900 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 52
States / cities: Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 44 more

Conditions: Stroke
Interventions: Hand of Hope (HOH); Device
Lead sponsor: Rehab-Robotics Company Limited; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Stroke
Interventions: OPUS-i algorithm; Other
Lead sponsor: Temple University; Other
Eligibility: 18 Years and older
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Camden, New Jersey • Philadelphia, Pennsylvania

Conditions: Cerebrovascular Accident, Intracranial Hypertension
Interventions: 3-D ultrasound scanner, Perflutren Protein-Type A Microspheres for injection; Device · Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Post-Ischemic Stroke
Interventions: Placebo, dalfampridine-ER 7.5mg, dalfampridine-ER 10mg; Drug
Lead sponsor: Acorda Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 377 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 70
States / cities: Gilbert, Arizona • Berkeley, California • Long Beach, California + 61 more

Search by objective public record fields.

Drug-Drug Interaction Study Between AT1001 (Migalastat Hydrochloride) and Agalsidase in Participants With Fabry Disease

Enhancing Resilience in Young Stroke Survivors With Res-ET

International Care Bundle Evaluation in Cerebral Hemorrhage Research

Barrow Ruptured Aneurysm Trial

Speed of Processing Training in Traumatic Brain Injury

Impact of Intraoperative Oxygenation Practices on Patient Outcomes

Rehabilitation Device for Hand Mirror Therapy

Optical Coherence Tomography Angiography in Neurological Disease

Feasibility of Home Telehealth Monitoring for Improvement in Management of Hypertension for Secondary Stroke Prevention

Hydrogel Balloon Assisted Intracranial Aneurysm Coiling Registry

E-Rehabilitation: Aerobic Resistance Training for Stroke Survivors

Mindfulness Based Stress Reduction and Post-Stroke Cognition

Clinical Feasibility of Transcranial Direct Current Stimulation [tDCS] With Standard Aphasia Therapy

Ustekinumab for the Treatment of Giant Cell Arteritis

GORE Flow Reversal System and GORE Embolic Filter Extension Study

Extracorporeal Filtration of Subarachnoid Hemorrhage Via Spinal Catheter

International Subarachnoid Aneurysm Trial II

Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)

Efficacy Study of Kinto Care Coaching for Dementia Family Caregivers

Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)

Portable EMG-triggered Hand Robot for Individuals After Stroke

Optimizing the Prehospital Use of Stroke Systems of Care-Reacting to Changing Paradigms-Implementation (OPUS-i)

3-D Transcranial Ultrasound Analysis Study

A Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets.